Which Patients with Isolated Para-aortic Lymph Node Metastasis Will Truly Benefit from Extended Lymph Node Dissection for Colon Cancer?

Cancer Research and Treatment 2018³â 50±Ç 3È£ p.712 ~ p.719

¹è¼º¿í(Bae Sung-Uk) - Keimyung University School of Medicine Dongsan Medical Center Department of Surgery
(Hur Hyuk) - Yonsei University College of Medicine Severance Hospital Department of Surgery
¹Îº´¼Ò(Min Byung-Soh) - Yonsei University College of Medicine Severance Hospital Department of Surgery
¹é½ÂÇõ(Baik Seung-Hyuk) - Yonsei University College of Medicine Severance Hospital Department of Surgery
ÀÌ°­¿µ(Lee Kang-Young) - Yonsei University College of Medicine Severance Hospital Department of Surgery
±è³²±Ô(Kim Nam-Kyu) - Yonsei University College of Medicine Severance Hospital Department of Surgery

Abstract

Purpose: The prognosis of patientswith colon cancer and para-aortic lymph node metastasis (PALNM) is poor. We analyzed the prognostic factors of extramesenteric lymphadenectomy for colon cancer patients with isolated PALNM.

Materials and Methods: We retrospectively reviewed 49 patients with PALNM who underwent curative resection between October 1988 and December 2009.

Results: In univariate analyses, the 5-year overall survival (OS) and disease-free survival (DFS) rates were higher in patients with ¡Â 7 positive para-aortic lymph node (PALN) (36.5% and 27.5%) than in those with > 7 PALN (14.3% and 14.3%; p=0.010 and p=0.027, respectively), and preoperative carcinoembryonic antigen (CEA) level > 5 was also correlated with a lower 5-year OS and DFS rate of 21.5% and 11.7% compared with those with CEA ¡Â 5 (46.3% and 41.4%; p=0.122 and 0.039, respectively). Multivariate analysis found that the number of positive PALN (hazard ratio [HR], 3.291; 95% confidence interval [CI], 1.309 to 8.275; p=0.011) was an independent prognostic factor for OS and the number of positive PALN (HR, 2.484; 95% CI, 0.993 to 6.211; p=0.052) and preoperative CEA level (HR, 1.953; 95% CI, 0.940 to 4.057; p=0.073) were marginally independent prognostic factors for DFS. According to our prognostic model, the 5-year OS and DFS rate increased to 59.3% and 53.3%, respectively, in patients with ¡Â 7 positive PALN and CEA level ¡Â 5.

Conclusion: PALN dissection might be beneficial in carefully selected patients with a low CEA level and less extensive PALNM.

Å°¿öµå

Colonic neoplasms, Lymph nodes, Lymph node excision, Lymphatic metastasis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
The 5-year OS and DFS rates were higher in patients with ¡Â 7 positive PALN (36.5% and 27.5%) than in those with > 7 PALN (14.3% and 14.3%; p=0.010 and p=0.027, respectively).
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå